The scope of IP protection in the biotechnology and life sciences sectors in Canada and the extent that such IP rights may preserve market exclusivity has been shaped by a number of recent authoritative judicial decisions. Arthur Renaud and Martin Kratz of
Bennett Jones look at two areas that have particularly been shaped by the courts
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
Egypt launches national IP strategy; Goodyear loses trade secrets case; Crocs and Walmart settle; Maradona rights owner reaches new deal; Steve Perry seeks TM cancellation; Mewburn Ellis wins sustainability award